Table 3.
Differences between vaccinated and unvaccinated groups.
| Variable | Levene’s sig. | t (adjusted) | p-value | Mean difference (vaccinated–unvaccinated) | 95% CI |
|---|---|---|---|---|---|
| HPV knowledge total score | <0.001 | −6.019 | <0.001 | −1.305 | [−1.720, −0.890] |
| Perceived benefits | <0.001 | −2.056 | 0.040 | −0.290 | [−0.570, −0.010] |
| Perceived susceptibility | 0.986 | −6.377 | <0.001 | −0.679 | [−0.890, −0.470] |
| Perceived severity | 0.037 | −4.424 | <0.001 | −0.749 | [−1.080, −0.420] |
| Perceived barriers | <0.001 | 4.550 | <0.001 | 1.009 | [0.570, 1.450] |
| Vaccine concerns | <0.001 | 3.972 | <0.001 | 1.061 | [0.540, 1.580] |
| Perceived inconvenience | <0.001 | 10.125 | <0.001 | 2.832 | [2.230, 3.420] |
The vaccinated group is defined as participants who have received at least one dose of HPV vaccine.